An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults	Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease	Recruiting	Phase 3	2026-06-29		NCT07467707

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Armed Forces Research Institute of Medical Services	1
Bavarian Nordic	9
Congressionally Directed Medical Research Programs	87
Pharmaceutical Product Development, (PPD) LLC	1
Q-square Business Intelligence, Inc.	1
United States Department of Defense	319
Walter Reed Army Institute of Research (WRAIR)	16

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Kamphaeng Phet Provincial Hospital	Kamphaeng Phet	Thailand	1
Songklanagarind hospital, Prince of Songkla University (PSU)	Hat Yai	Thailand	1
WRAIR-AFRIMS Philippines, Cebu (WRAIR-APC)	Cebu City	Philippines	1